Purpose: To evaluate the relationship between the T2 patterns of spinal cord multiple sclerosis lesions and their contrast uptake.
Material and method: We retrospectively reviewed the appearance of spinal cord lesions in 29 patients (with relapsing-remitting multiple sclerosis) who had signs and symptoms of myelopathy on neurologic examination and at least one active lesion visualized on magnetic resonance examinations performed between 2004 and 2011. We correlated the T2 patterns of lesions with contrast enhancement and calculated sensitivity and specificity in predicting gadolinium enhancement.
Results: Only focal patterns consisting of a lesion’s center homogenously brighter than its periphery on T2-weighed images (type I) correlated significantly with the presence of contrast enhancement (p = 0.004). Sensitivity was 0.307 and specificity 0.929. In contrast, enhancement was not significantly related to uniformly hyperintense T2 focal lesions (type II) or diffuse (type III) pattern defined as poorly delineated areas of multiple small, confluent, subtle hyperintense T2 lesions (p > 0.5 for both).
Conclusions: We believe that information about the activity of multiple sclerosis spinal cord lesions in patients with myelopathy may be extracted not only from contrast enhanced, but also from non-enhanced magnetic resonance images.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Bot JC Barkhof F Lycklama a Nijeholt G et al. Differentiation of multiple sclerosis from other infl ammatory disorders and cerebrovascular disease: Value of spinal MR imaging. Radiology. 2002;223:46-56.
2. Sahraian MA Radue EW-MRI. Gadolinium enhancing lesions in multiple sclerosis in Atlas of MS lesions. Springer-Verlag Berlin 2008 45-65.
3. Nesbit GM Forbes GS Scheithauer BW Okazaki H Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology. 1991;180(2):467-474.
4. Lucchinetti CF Brück WB Rodriguez M Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathology. 1996;6(3):259-274.
5. Soon D Tozer DJ Altmann DR Tofts PS Miller DH. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Multiple Sclerosis.2007;13(7):884-894.
6. He J Grossman RI Ge Y Mannon LJ - Enhancing patterns in multiple sclerosis: evolution and persistence. AJNR Am J Neuroradiol. 2001;22: 664-669.
7. Yousry I Filippi M Walther E Gasperini C Capra R Yousry TA. Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose. Magn Reson Imaging. 2000;18(9):1183-1186.
8. Dillman JR Ellis JH Cohan RH Strouse PJ Jan SC. Frequency and severity of acute allergic-like reactions to Gadolinium-containing iv contrast media in children and adults. Americal Journal of Roengenology. 2007;189(6):1533-1538.
9. Trop I Bourgouin PM Lapierre Y et al. Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. AJNR Am J Neuroradiol. 1998;19:1025-1033